Moleculin Announces Engagement with Voisin Consulting Life Sciences to Expand Annamycin Clinical Trial

May 3, 2018 by Website Admin in

Moleculin announced that it has engaged Voisin Consulting Life Sciences as an additional regulatory consulting firm and contract research organization.

Tweet

Share

Pin it

Previous StoryLivaNova Completes Sale of Cardiac Rhythm Management Business to MicroPort Scientific Corporation Next StoryBellicum Announces Presentation on Dual-Switch CAR-T Technology at the 21st Annual Meeting of the American Society of Gene and Cell Therapy